Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Turner

Showing results (341-350 of 362) with videos related to

Pageof 37
Sort By:
Gut|February 14, 2023
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesisHaim Leibovitzh, Sun-Ho Lee, Juan Antonio Raygoza Garay, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2022
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHANAnat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, et al.
Gastroenterology|July 19, 2022
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's DiseaseHaim Leibovitzh, Sun-Ho Lee, Mingyue Xue, et al.
Gastroenterology|June 21, 2011
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitisAleixo M Muise, Thomas Walters, Wei Xu, et al.
Gastroenterology|September 5, 2024
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's DiseasePablo A Olivera, Helena Martinez-Lozano, Haim Leibovitzh, et al.
Gastroenterology|May 29, 2026
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk CohortMingyue Xue, Cathy McShane, Jeongseok Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2018
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseasesYue Li, Marita Führer, Ehsan Bahrami, et al.
Journal of Crohn'S & Colitis|November 28, 2024
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter StudyAnat Yerushalmy-Feler, Elizabeth A Spencer, Michael T Dolinger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2024
Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial ProjectMingyue Xue, Haim Leibovitzh, Shao Jingcheng, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective StudyShlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, et al.
Pageof 37

Showing results (341-350 of 362) with videos related to

Sort By:
Pageof 37
Gut|February 14, 2023
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesisHaim Leibovitzh, Sun-Ho Lee, Juan Antonio Raygoza Garay, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2022
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHANAnat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, et al.
Gastroenterology|July 19, 2022
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's DiseaseHaim Leibovitzh, Sun-Ho Lee, Mingyue Xue, et al.
Gastroenterology|June 21, 2011
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitisAleixo M Muise, Thomas Walters, Wei Xu, et al.
Gastroenterology|September 5, 2024
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's DiseasePablo A Olivera, Helena Martinez-Lozano, Haim Leibovitzh, et al.
Gastroenterology|May 29, 2026
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk CohortMingyue Xue, Cathy McShane, Jeongseok Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2018
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseasesYue Li, Marita Führer, Ehsan Bahrami, et al.
Journal of Crohn'S & Colitis|November 28, 2024
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter StudyAnat Yerushalmy-Feler, Elizabeth A Spencer, Michael T Dolinger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2024
Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial ProjectMingyue Xue, Haim Leibovitzh, Shao Jingcheng, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective StudyShlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, et al.
Pageof 37